Unresectable Renal Cell Carcinoma Recruiting Phase 2 Trials for Pazopanib (DB06589)

IndicationStatusPhase
DBCOND0115886 (Unresectable Renal Cell Carcinoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03334409Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by SurgeryTreatment